Emgality (generic name: galcanezumab) is used to prevent migraines in adults.
It belongs to a class of drugs called calcitonin gene-related peptide (CGRP) inhibitors. These drugs work by blocking the activity of CGRP, a protein associated with migraine attacks.
Emgality is administered via subcutaneous injection.
Dosage
It is important to follow the instructions on how to properly inject this medication. The usual dosage of Emgality for migraine prevention is an initial loading dose of 240 mg (administered as two consecutive 120 mg injections), followed by monthly maintenance doses of 120 mg.
If you miss a dose, take it as soon as you remember, then continue with your regular monthly schedule. Do not double-dose to make up for a missed one.
Storage
Store Emgality in the refrigerator at 2°-8°C (36°-46°F) in its original carton to protect it from light. Do not freeze. If necessary, Emgality can be kept at room temperature up to 30°C (86°F) for a maximum of 7 days. Once stored at room temperature, do not return it to the refrigerator.
Keep out of reach of children.
Common Questions About Emgality
Can I self-inject Emgality at home?
Yes, after instruction from a trained healthcare provider, you can self-inject Emgality at home. Ensure you follow the injection instructions carefully.
What is galcanezumab, and how does it work?
Galcanezumab is a monoclonal antibody that targets and inhibits calcitonin gene-related peptide (CGRP), a protein involved in migraine attacks. By blocking CGRP, it helps prevent migraines.
How effective is Emgality in preventing migraines?
Clinical studies have shown that Emgality significantly reduces the number of migraine days per month in individuals with frequent migraines. Individual results may vary
This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.
Read the information leaflet that comes with the medication.
Most people who use Emgality do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.
Some of the side effects that have been reported include:
Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.
Emgality is indicated for the prevention of migraine in adults who experience frequent migraine attacks. By inhibiting calcitonin gene-related peptide (CGRP), Emgality helps reduce the frequency and severity of migraine episodes.